Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Does HIV reporting by name deter testing? MESH Study Group.

F M Hecht1, M A Chesney, J S Lehman

  • 1Positive Health Program HIV Section, University of California at San Francisco, 94110, USA. rhecht@php.ucsf.edu

AIDS (London, England)
|September 14, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Observation of Charmonium Sequential Suppression in Heavy-Ion Collisions at the Relativistic Heavy Ion Collider.

Physical review letters·2026
Same author

Energy Independence of the Collins Asymmetry in p^{↑}p Collisions.

Physical review letters·2026
Same author

Review of the first 5 years of dedicated FDG PET/CT for Cardiac Inflammation.

Irish medical journal·2025
Same author

Precision Measurement of Net-Proton-Number Fluctuations in Au+Au Collisions at RHIC.

Physical review letters·2025
Same author

Measurement of Two-Point Energy Correlators within Jets in p+p Collisions at sqrt[s]=200  GeV.

Physical review letters·2025
Same author

Onset of Constituent Quark Number Scaling in Heavy-Ion Collisions at RHIC.

Physical review letters·2025
Same journal

Hazardous alcohol use, sexual behavior, and recent and undiagnosed HIV across 11 Eastern and Southern African countries.

AIDS (London, England)·2026
Same journal

Carotid inflammation on FDG-PET is associated with lower cognitive performance in people with treated HIV infection.

AIDS (London, England)·2026
Same journal

Clinical implications of the new definition of obesity among persons with HIV.

AIDS (London, England)·2026
Same journal

Cabotegravir and rilpivirine resistance-associated mutations among people with newly diagnosed HIV-1 in the Netherlands.

AIDS (London, England)·2026
Same journal

Pitavastatin effect on enterocyte injury markers in an ART treated HIV population: Insights from REPRIEVE.

AIDS (London, England)·2026
Same journal

Blood pressure control in people with HIV and established atherosclerotic cardiovascular disease: a real-world descriptive analysis.

AIDS (London, England)·2026
See all related articles

Most people at risk for HIV do not know their state's reporting policy. Name-based HIV reporting may delay testing for some, but does not appear to deter individuals from getting tested.

Area of Science:

  • Public Health
  • Epidemiology
  • Health Policy

Background:

  • Name-based HIV reporting in the US is controversial.
  • Concerns exist that it may discourage high-risk individuals from HIV testing.

Purpose of the Study:

  • To assess awareness of state HIV reporting policies among at-risk populations.
  • To determine if reporting policies influence HIV testing behavior (delays or avoidance).

Main Methods:

  • Anonymous cross-sectional survey of 2404 participants.
  • Included men who have sex with men (MSM), heterosexuals in STD clinics, and street-recruited injection drug users (IDU).
  • Survey conducted in eight US states (four with name-based reporting, four without).

Main Results:

Keywords:
Empirical ApproachHealth Care and Public Health

Related Experiment Videos

  • Less than 25% correctly identified their state's HIV reporting policy.
  • Over 50% were unaware if their state used name-based reporting.
  • Name-based reporting was not significantly associated with avoiding testing, but was linked to delays in testing for IDU and potentially MSM.

Conclusions:

  • Lack of awareness regarding HIV reporting policies is widespread among at-risk populations.
  • Name-based reporting does not appear to deter HIV testing but may contribute to testing delays for certain groups, particularly IDU.